Wilbert Matthews

649 total citations
24 papers, 553 citations indexed

About

Wilbert Matthews is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Wilbert Matthews has authored 24 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Wilbert Matthews's work include Photodynamic Therapy Research Studies (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Wilbert Matthews is often cited by papers focused on Photodynamic Therapy Research Studies (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Wilbert Matthews collaborates with scholars based in United States. Wilbert Matthews's co-authors include Harvey I. Pass, Steven J. Evans, Helen W. Pogrebniak, Douglas L. Fraker, Jeffrey A. Norton, Paul B. Chretien, Herbert K. Oie, Maria Tsokos, Patricia Fetsch and Daphne Mew and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and British Journal of Cancer.

In The Last Decade

Wilbert Matthews

24 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wilbert Matthews United States 13 323 169 145 75 67 24 553
Charles Hudd United Kingdom 8 236 0.7× 89 0.5× 262 1.8× 78 1.0× 98 1.5× 20 815
Venkateswara R. Naraparaju United States 12 89 0.3× 72 0.4× 174 1.2× 124 1.7× 63 0.9× 15 503
Simona Inghilleri Italy 14 332 1.0× 48 0.3× 154 1.1× 65 0.9× 53 0.8× 29 585
Kazuya Hirano Japan 18 183 0.6× 86 0.5× 449 3.1× 136 1.8× 96 1.4× 41 871
Gerald B. Dermer United States 17 222 0.7× 30 0.2× 253 1.7× 38 0.5× 73 1.1× 33 757
Angelina Di Carlo Italy 19 200 0.6× 60 0.4× 303 2.1× 69 0.9× 244 3.6× 37 777
Hailong Pei China 17 149 0.5× 95 0.6× 390 2.7× 61 0.8× 211 3.1× 49 734
Shanshan Qin China 10 94 0.3× 130 0.8× 166 1.1× 96 1.3× 42 0.6× 32 480
Zhuangzhuang Zheng China 17 257 0.8× 135 0.8× 312 2.2× 160 2.1× 207 3.1× 39 851

Countries citing papers authored by Wilbert Matthews

Since Specialization
Citations

This map shows the geographic impact of Wilbert Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilbert Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilbert Matthews more than expected).

Fields of papers citing papers by Wilbert Matthews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilbert Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilbert Matthews. The network helps show where Wilbert Matthews may publish in the future.

Co-authorship network of co-authors of Wilbert Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Wilbert Matthews. A scholar is included among the top collaborators of Wilbert Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilbert Matthews. Wilbert Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howe, S R, Harvey I. Pass, Stephen P. Ethier, Wilbert Matthews, & Cheryl L. Walker. (1996). Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen.. PubMed. 56(17). 4049–55. 21 indexed citations
2.
Pass, Harvey I., Emily J. Stevens, Herbert K. Oie, et al.. (1995). Characteristics of nine newly derived mesothelioma cell lines. The Annals of Thoracic Surgery. 59(4). 835–844. 112 indexed citations
3.
Matthews, Wilbert, et al.. (1994). Tumor necrosis factor induces doxorubicin resistance to lung cancer cells in vitro. Journal of Thoracic and Cardiovascular Surgery. 107(1). 43–49. 16 indexed citations
4.
Pogrebniak, Helen W., Wilbert Matthews, C M Black, et al.. (1993). Targetted phototherapy with sensitizer-monoclonal antibody conjugate and light. Surgical Oncology. 2(1). 31–42. 16 indexed citations
5.
Pogrebniak, Helen W., Wilbert Matthews, & Harvey I. Pass. (1992). Alterations in macrophage free radical and tumor necrosis factor production by a potassium channel activator. Journal of Surgical Research. 52(4). 395–400. 17 indexed citations
6.
Pogrebniak, Helen W., Wilbert Matthews, Jane A. Mitchell, et al.. (1991). Spin trap protection from tumor necrosis factor cytotoxicity. Journal of Surgical Research. 50(5). 469–474. 26 indexed citations
7.
Pogrebniak, Helen W., Wilbert Matthews, & Harvey I. Pass. (1991). Chemotherapy amplifies production of tumor necrosis factor.. PubMed. 110(2). 231–7. 26 indexed citations
8.
Evans, Steven J., et al.. (1990). Effect of Photodynamic Therapy on Tumor Necrosis Factor Production by Murine Macrophages. JNCI Journal of the National Cancer Institute. 82(1). 34–39. 142 indexed citations
9.
Perry, Roger R, Wilbert Matthews, James B. Mitchell, et al.. (1990). Sensitivity of different human lung cancer histologies to photodynamic therapy.. PubMed. 50(14). 4272–6. 32 indexed citations
10.
Perry, Roger R, et al.. (1989). Potentiation of phototherapy cytotoxicity with light scattering media. Journal of Surgical Research. 46(4). 386–390. 8 indexed citations
11.
Matthews, Wilbert, et al.. (1989). In vitro photodynamic therapy of human lung cancer. Journal of Surgical Research. 47(3). 276–281. 13 indexed citations
12.
Matthews, Wilbert, John A. Cook, James B. Mitchell, et al.. (1989). In vitro photodynamic therapy of human lung cancer: investigation of dose-rate effects.. PubMed. 49(7). 1718–21. 24 indexed citations
13.
Am, Eggermont, et al.. (1987). Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2. British Journal of Cancer. 56(2). 97–102. 9 indexed citations
14.
Ottow, R. T., et al.. (1987). Augmentation of Interleukin-2 Immunotherapeutic Effects by Lymphokine-Activated Killer Cells and Allogeneic Stimulation in Murine Tumor Cells. JNCI Journal of the National Cancer Institute. 79(5). 983–90. 9 indexed citations
15.
Matthews, Wilbert. (1986). Multiple Sclerosis Research in Europe. Journal of Neurology Neurosurgery & Psychiatry. 49(9). 1096–1096. 7 indexed citations
16.
Matthews, Wilbert, et al.. (1986). Recruitment of inflammatory cells to a tumor deposit potentiates the immunotherapeutic effects of interleukin-2. Cancer Immunology Immunotherapy. 23(3). 4 indexed citations
17.
Sugarbaker, Paul H. & Wilbert Matthews. (1985). Alloantigen-Activated Lysis of Syngenic Tumor Augmented by Allogenic Lymphocytes as Cold Targets. Oncology. 42(6). 377–383. 2 indexed citations
18.
Sugarbaker, Paul H. & Wilbert Matthews. (1981). Cytotoxic cells suppress in vitro generation of cellular immunity by stimulator cell lysis. Cellular Immunology. 57(1). 124–135. 3 indexed citations
19.
Chretien, Paul B., Wilbert Matthews, & Patrick Twomey. (1973). Serum ribonucleases in cancer: Relation to tumor histology. Cancer. 31(1). 175–179. 33 indexed citations
20.
Catàlona, William J., Paul B. Chretien, Wilbert Matthews, & John L. Tarpley. (1973). Serum ribonuclease in urologic cancer Relation to host immunocompetence. Urology. 2(5). 577–581. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Hudd Breakdown of academic impact, for papers by Venkateswara R. Naraparaju Breakdown of academic impact, for papers by Simona Inghilleri Breakdown of academic impact, for papers by Kazuya Hirano Breakdown of academic impact, for papers by Gerald B. Dermer Breakdown of academic impact, for papers by Angelina Di Carlo Breakdown of academic impact, for papers by Hailong Pei Breakdown of academic impact, for papers by Shanshan Qin Breakdown of academic impact, for papers by Zhuangzhuang Zheng
Rankless by CCL
2026